Showing results (221-230 of 331) with videos related to
Sort By:
Pageof 34
Journal of Hepatology|January 1, 1986
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studiesL J Scully, A M Lever, I Yap, et al.British Journal of Cancer|July 1, 1982
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodiesA A Epenetos, C C Nimmon, J Arklie, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 2004
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell linesN A C S Wong, M P Britton, G S Choi, et al.Gut|July 18, 2000
The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in KoreaH C Kim, J M Wheeler, J C Kim, et al.Behavioural Brain Research|February 28, 2002
Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability ratG Grammatikopoulos, M Pignatelli, F D'Amico, et al.Gut|April 15, 2003
Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell linesA Buda, D Qualtrough, M A Jepson, et al.Journal of Hepatology|February 1, 1987
Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis. Evidence that antibody modulation may cause protracted infectionM Pignatelli, J Waters, A Lever, et al.Infection|January 1, 1987
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.Science (New York, N.Y.)|May 24, 1996
Polyclonal origin of colonic adenomas in an XO/XY patient with FAPM R Novelli, J A Williamson, I P Tomlinson, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2005
CDX1 is an important molecular mediator of Barrett's metaplasiaN A C S Wong, J Wilding, S Bartlett, et al.Pageof 34